|Item 4.|| |
Purpose of Transaction
Item 4 of the Schedule 13D is hereby amended to add the following:
In connection with the Reporting Persons’ “vote no” campaign (as disclosed in Amendment No. 1 to this Schedule 13D), on July 8, 2021, Mr. O’Shaughnessy made public a letter to shareholders outlining certain reasons for shareholders to vote against four directors of the Issuer at the annual meeting of shareholders of the Issuer. A copy of the letter is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The Reporting Persons strongly advise all shareholders of the Issuer to read these materials.